The Gemigliptin Market Size is valued at USD 1.66 billion in 2022 and is predicted to reach USD 2.65 billion by the year 2031 at a 5.5% CAGR during the forecast period for 2023-2031. Key Industry Insights & Findings from the Report: Gemigliptin effectiveness in glycemic control, often in combination with other antidiabetic agents, has contributed to its widespread adoption. Greater awareness among patients about the importance of glycemi...
Report ID: 2031 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Market Size is valued at USD 19.49 Bn in 2023 and is predicted to reach USD 33.61 Bn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The increasing government initiatives and investments for research and developments drive the market growth. Rising clinical trials as well as awareness for the COP...
Report ID: 2311 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 179
Pharmaceutical Fine Chemicals Market Size is valued at USD 133.8 Bn in 2023 and is predicted to reach USD 246.5 Bn by the year 2031 at a 8.15% CAGR during the forecast period for 2024-2031. Pharmaceutical fine chemicals describe the class of chemicals that are employed in the pharmaceutical industry. In contrast to the processed compounds found in most pharmaceuticals, they are pure substances. The number of people with various chronic health...
Report ID: 2462 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Biomarker Discovery Outsourcing Services Market Size is valued at USD 12.16 billion in 2023 and is predicted to reach USD 52.82 billion by the year 2031 at a 20.38% CAGR during the forecast period for 2024-2031. Key Industry Insights & Findings from the Report: The market for biomarker discovery outsourcing services is anticipated to be driven by a rise in the use of targeted medicines. Another major driver of the market for b...
Report ID: 2191 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 179
Chlorphenamine Maleate API Market Size is valued at USD 70.2 Mn in 2023 and is predicted to reach USD 120.5 Mn by the year 2031 at a 7.20% CAGR during the forecast period for 2024-2031. Chlorphenamine maleate is an important active pharmaceutical ingredient (API) in the pharmaceutical industry due to its proven effectiveness and wide range of uses in treating symptoms related to different allergic responses. The Chlorphenamine maleat...
Report ID: 2463 |
Delivery: Immediate |
Published: May 2024 |
No. of Pages: 180
Gene Therapy on Cardiovascular Disease Market Size is predicted to grow at a 67.4% CAGR during the forecast period for 2024-2031. Gene therapy for cardiovascular disease shows promising potential but is primarily in the experimental and clinical trial stages. Achievement in this domain has the potential to result in groundbreaking therapies for conditions that presently possess restricted therapeutic alternatives. One approach to gene therapy ...
Report ID: 2451 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Microbiome Manufacturing Market Size is valued at USD 27.3 Mn in 2023 and is predicted to reach USD 84.8 Mn by the year 2031 at a 15.4% CAGR during the forecast period for 2024-2031. Microbiome manufacture integrates sophisticated biotechnological techniques with a deep comprehension of microbial ecosystems, rendering it a state-of-the-art field of advancement with extensive implications for medicine, nutrition, and general health. The microbi...
Report ID: 2458 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Liposomal and Lipid Nanoparticle Drug Delivery Systems Market Size is valued at USD 5.4 Bn in 2023 and is predicted to reach USD 10.8 Bn by the year 2031 at a 9.3% CAGR during the forecast period for 2024-2031 Both liposomal and lipid nanoparticle systems are notable advancements in drug delivery technology, specifically for delivering therapeutic compounds that are challenging to administer due to stability or toxicity concerns. Their progres...
Report ID: 2459 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Levonorgestrel API Market Size was valued at USD 52.01 Mn in 2023 and is predicted to reach USD 71.37 Mn by 2031 at a 4.13% CAGR during the forecast period for 2024-2031. Levonorgestrel is a medicine that is mostly prescribed for the purpose of preventing pregnancy. There are many ways to actively use this hormone drug to control birth. If all other methods of preventing pregnancy have been exhausted, an emergency contraceptive may be utilized...
Report ID: 2460 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 179
Adrenocortical Hormones API Market Size is valued at USD 2.24 Bn in 2023 and is predicted to reach USD 3.55 Bn by the year 2031 at a 6.04% CAGR during the forecast period for 2024-2031. Adrenocortical hormones, also referred to as corticosteroids or adrenal cortex hormones, are steroid hormones synthesized by the adrenal cortex, which is a component of the adrenal gland. This hormone is synthesized or extracted to be used as API (Active P...
Report ID: 2453 |
Delivery: Immediate |
Published: April 2024 |
No. of Pages: 180
Pharmaceuticals